| Bioactivity | AMY-101 (Cp40), a peptidic inhibitor of the central complement component C3 (KD = 0.5 nM), inhibits naturally occurring periodontitis in non-human primates (NHPs). AMY-101 (Cp40) exhibits a favorable anti-inflammatory activity in models with COVID-19 severe pneumonia with systemic hyper inflammation[1][2]. |
| Name | AMY-101 |
| CAS | 1427001-89-5 |
| Shortening | YICV-{Trp(Me)}-QDW-{Sar}-AHRC-{N(Me)Ile}-NH2 (Disulfide bridge:Cys3-Cys13) |
| Formula | C83H117N23O18S2 |
| Molar Mass | 1789.11 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
AMY-101
CAS: 1427001-89-5 F: C83H117N23O18S2 W: 1789.11
AMY-101 (Cp40), a peptidic inhibitor of the central complement component C3 (KD = 0.5 nM), inhibits naturally occurring
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.